Organon is primarily engaged in manufacturing, fabricating or processing drugs in pharmaceutical preparations for human or veterinary use. Its products consist of pharmaceutical preparations promoted primarily to the dental, medical or veterinary professions, and pharmaceutical preparations mostly for the public. Organon has a market value of $6.89 billion. Specifically, Organon focuses on women’s health, biosimilars and established medicines. Organon has more than 60 medicines and other products in areas including reproductive health, heart disease, dermatology, allergies and asthma. It has an international footprint that serves people in more than 140 markets.

Visit the Organon website

About Us



Partners & Members

  • Sign in
  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum